Publication of Biohit Oyj Renumeration Report 2022

Biohit Oyj Renumeration Report March 22, 2023 at 9:30 am local time (EET)

Biohit Oyj’s Remuneration Report for the Governing Bodies is published today in PDF format. The Remuneration Report for the Governing Bodies is attached to this stock exchange release and also available at https://www.biohithealthcare.com/en/investors/.

Additional information:

CEO Jussi Hahtela, Biohit Oyj
tel. +358 9 773 861
[email protected]
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com